Filing Details
- Accession Number:
- 0001104659-22-117847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-14 08:40:35
- Reporting Period:
- 2022-11-10
- Accepted Time:
- 2022-11-14 08:40:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1635088 | Roivant Sciences Ltd. | ROIV | Pharmaceutical Preparations (2834) | 981173944 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636684 | Ltd. Holdings Dexxon | 1 Dexcel Street Or Akiva L3 3060000 | No | No | Yes | No | |
| 1636701 | Dan Oren | 1 Dexcel Street Or Akiva L3 3060000 | No | No | Yes | No | |
| 1720007 | Ltd. Technologies Pharma Dexcel | 21 Nahum Haftzadi Street Jerusalem L3 9548402 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-11-10 | 4,000,000 | $5.00 | 102,849,443 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Dexcel Pharma Technologies Ltd. ("Dexcel") is the direct beneficial holder of 4,684,130 common shares. Dexxon Holding Ltd. ("Dexxon") is the direct beneficial holder of 98,165,313 common shares. Dan Oren is the Executive Chairman of Dexcel and the sole director of Dexxon and is ultimately the sole shareholder of each entity.
- The common shares were purchased by Dexcel in a registered public offering on November 10, 2022.
Billionaire Hedge Funds
